· ARPEGE is designed to achieve solutions to antibiotic resistance by combining preventive, diagnostic, therapeutic and economic approaches for the first time.
· Led by the French biotech company Antabio, the ARPEGE consortium is acting jointly with bioMérieux, Hospices Civils de Lyon, and Toulouse School of Economics.
· ARPEGE is of major importance for public health, using a ground-breaking model to provide a framework for innovation and to strengthen the ability of healthcare systems.
PR Newswire
LABÈGE, TOULOUSE, MARCY L'ETOILE and LYON, France, Jan. 6, 2022